Research is examining the safety and tolerability of two different doses of ABX464 in patients with moderate to severe active RA…
Abx464 Enters Phase 2 Clinical Trials for RA in Europe
In Europe, researchers are evaluating the safety, tolerability and efficacy of ABX464 in rheumatoid arthritis patients…